Table 1.
Control (n = 191) | Digital therapeutics (n = 199) | |
---|---|---|
Age (years) | 52.0 (7.6) | 52.4 (8.1) |
Female sex | 43 (23) | 35 (18) |
Body mass index (kg/m2) | 25.2 (23.0–28.0) | 25.2 (23.0–27.8) |
Waist circumference (cm) | 88.8 (82.5–95.0) | 87.0 (81.8–95.0) |
Current smoker | 29 (15) | 33 (17) |
History of antihypertensive drug use | 26 (14) | 31 (16) |
Comorbidities | ||
Dyslipidaemia | 91 (48) | 104 (52) |
Diabetes mellitus | 14 (7) | 12 (6) |
Proteinuria | 14 (7) | 13 (7) |
Non-valvular atrial fibrillation | 1 (1) | 2 (1) |
Medical history | ||
Brain haemorrhage | 0 (0) | 0 (0) |
Stroke | 0 (0) | 0 (0) |
Myocardial infarction | 0 (0) | 0 (0) |
Blood pressure at baseline (mmHg) | ||
24-h SBP | 144.3 (10.4) | 144.9 (10.4) |
24-h DBP | 94.3 (7.2) | 95.0 (8.2) |
Morning home SBP | 147.0 (13.3) | 149.3 (12.4) |
Morning home DBP | 94.0 (9.9) | 94.7 (8.7) |
Evening home SBP | 140.6 (12.6) | 143.3 (14.3) |
Evening home DBP | 88.2 (10.5) | 89.8 (9.9) |
Office SBP | 153.2 (10.5) | 154.1 (10.0) |
Office DBP | 97.9 (6.9) | 98.8 (7.2) |
Values are mean (standard deviation), median (interquartile range), or n (%).
DBP, diastolic blood pressure; SBP, systolic blood pressure.